Mapping the landscape of brain stimulation research: A global scientometric review on cognitive impairment

Abstract

Several noninvasive brain stimulation techniques have gained significant attention in neurocognitive science and clinical research due to their potential efficacy in addressing neurological, psychiatric, and cognitive impairments. This study explores global trends and research hotspots in brain stimulation research for cognitive impairment and related disorders. Using a data set from 1989 to 2024 sourced from the Web of Science Core Collection, 4156 records were analyzed through bibliometric methods, including publication trends, country or region, and institutional analysis, and document co-citation analysis (DCA). Results revealed a steady increase in research, with a significant increase in publications during the period from 2019 to 2023. The USA led in citation counts (1117), centrality (0.37), while China topped the burst value (72.31). The University of London led in citation counts (235), whereas Capital Medical University topped the sigma value (1.77). Transcranial magnetic stimulation (TMS) and repetitive TMS (rTMS) dominated the top positions in DCA analysis. Emerging trends were identified through burst keywords, including “transcranial Doppler,” “subthalamic nucleus stimulation,” “cerebral blood flow,” “vascular dementia,” and “cardiopulmonary bypass.” These emerging research hotspots underscore the growing focus on vascular aspects of cognitive impairment and advanced brain stimulation methods. Additionally, newer noninvasive techniques like fast gamma magnetic stimulation, paired-associative stimulation with TMS (PAS-TMS), and theta-burst stimulation are identified as promising avenues for future research, offering significant potential for therapeutic advancements. This study provides a comprehensive overview of the global landscape, trends, and future directions in brain stimulation research for cognitive impairment.

Keywords

bibliometrics / brain stimulation / CiteSpace / cognitive impairment / scientometrics / transcranial magnetic stimulation

References

[1] Sanford AM. Mild cognitive impairment. Clin Geriatr Med. 2017; 33(3): 325-337.

[2] McDonald WM. Overview of neurocognitive disorders. Focus. 2017; 15(1): 4-12.

[3] Association A. 2018 Alzheimer's disease facts and figures. Alzheimer's Dement. 2018; 14(3): 367-429.

[4] Šimko P, Kent JA, Rektorova I. Is non-invasive brain stimulation effective for cognitive enhancement in Alzheimer's disease? An updated meta-analysis. Clin Neurophysiol. 2022; 144: 23-40.

[5] Gauthier S, Rosa-Neto P, Morais JA, Webster C World Alzheimer Report 2021: Journey through the Diagnosis of Dementia. 2021. https://www.alzint.org/u/World-Alzheimer-Report-2021.pdf

[6] Gorelick PB, Scuteri A, Black SE, et al. Vascular contributions to cognitive impairment and dementia: A statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2011; 42(9): 2672-2713.

[7] Kloppel S, Stonnington CM, Chu C, et al. Automatic classification of MR scans in Alzheimer's disease. Brain. 2008; 131(3): 681-689.

[8] Benussi A, Di Lorenzo F, Dell'Era V, et al. Transcranial magnetic stimulation distinguishes Alzheimer disease from frontotemporal dementia. Neurology. 2017; 89(7): 665-672.

[9] Cicerone KD, Langenbahn DM, Braden C, et al. Evidence-based cognitive rehabilitation: updated review of the literature from 2003 through 2008. Arch Phys Med Rehabil. 2011; 92(4): 519-530.

[10] Gioia GA, Isquith PK. Ecological assessment of executive function In traumatic brain injury. Dev Neuropsychol. 2004; 25(1-2): 135-158.

[11] Nehra A, Sharma A, Sreenivas V, Bajpai S. Assessment and comparison of the memory profile in traumatic brain injury and subarachnoid hemorrhage patients. J Mental Health Human Behav. 2014; 19(1): 19.

[12] Poewe W. Treatments for Parkinson disease-past achievements and current clinical needs. Neurology. 2009; 72(7 suppl 2): 65-73.

[13] Rodriguez-Oroz MC, Obeso JA, Lang AE, et al. Bilateral deep brain stimulation in Parkinson's disease: A multicentre study with 4 years follow-up. Brain. 2005; 128(10): 2240-2249.

[14] Fellman D, Salmi J, Ritakallio L, Ellfolk U, Rinne JO, Laine M. Training working memory updating in Parkinson's disease: A randomised controlled trial. Neuropsychol Rehabil. 2020; 30(4): 673-708.

[15] Xue J, Li J, Liang J, Chen S. The prevalence of mild cognitive impairment in China: A systematic review. Aging Dis. 2018; 9(4): 706-715.

[16] Karim MA, Venkatachalam J. Prevalence of mild cognitive impairment of the elderly in Coimbatore district: a community-based study. Res Journey. 2021; A(269): 5-8. https://www.researchjourney.net/special-issues

[17] Petersen RC, Roberts RO, Knopman DS, et al. Prevalence of mild cognitive impairment is higher in men: the Mayo Clinic study of aging. Neurology. 2010; 75: 889-897. www.neurology.org

[18] Tsoy RT, Turuspekova ST, Klipitskaya NK, Mereke A, Cumming RG. Prevalence of mild cognitive impairment among older people in Kazakhstan and potential risk factors: a cross-sectional study. Alzheimer Dis Assoc Disord. 2019; 33(2): 136-141.

[19] Alkhunizan M, Alkhenizan A, Basudan L. Prevalence of mild cognitive impairment and dementia in Saudi Arabia: a community-based study. Dement Geriatr Cogn Dis Extra. 2018; 8(1): 98-103.

[20] Brookmeyer R, Abdalla N, Kawas CH. Forecasting the prevalence of preclinical and clinical Alzheimer's disease in the United States. Alzheimer's Dement. 2017; 14: 1-9.

[21] Niu H, Álvarez-Álvarez I, Guillén-Grima F, Aguinaga-Ontoso I. Prevalence and incidence of Alzheimer's disease in Europe: a meta-analysis. Neurología (English Edition). 2017; 32(8): 523-532.

[22] WHO. Global Health and Aging. 2011.

[23] Papapetropoulos S, Mash DC. Psychotic symptoms in Parkinson's disease. From description to etiology. J Neurol. 2005; 252: 753-764.

[24] Houeto JL. Behavioural disorders, Parkinson's disease and subthalamic stimulation. J Neurol Neurosurg Psychiatry. 2002; 72(6): 701-707.

[25] Krack P, Batir A, Van Blercom N, et al. Five-year follow-up of bilateral stimulation of the subthalamic nucleus in advanced Parkinson's disease from the departments of clinical and bio-logical neurosciences. N Engl J Med. 2003; 349: 1925-1959. www.nejm.org

[26] Funkiewiez A. Long term effects of bilateral subthalamic nucleus stimulation on cognitive function, mood, and behaviour in Parkinson's disease. J Neurol Neurosurg Psychiatry. 2004; 75: 834-839.

[27] Dayan E, Censor N, Buch ER, Sandrini M, Cohen LG. Noninvasive brain stimulation: from physiology to network dynamics and back. Nat Neurosci. 2013; 16(7): 838-844.

[28] Demirtas-Tatlidede A, Vahabzadeh-Hagh AM, Pascual-Leone A. Can noninvasive brain stimulation enhance cognition in neuropsychiatric disorders? Neuropharmacology. 2013; 64: 566-578.

[29] Chou Y, Ton That V, Sundman M. A systematic review and meta-analysis of rTMS effects on cognitive enhancement in mild cognitive impairment and Alzheimer's disease. Neurobiol Aging. 2020; 86: 1-10.

[30] Menardi A, Dotti L, Ambrosini E, Vallesi A. Transcranial magnetic stimulation treatment in Alzheimer's disease: a meta-analysis of its efficacy as a function of protocol characteristics and degree of personalization. J Neurol. 2022; 269(10): 5283-5301.

[31] Sabbagh M, Sadowsky C, Tousi B, et al. Effects of a combined transcranial magnetic stimulation (TMS) and cognitive training intervention in patients with Alzheimer's disease. Alzheimer's Dementia. 2020; 16(4): 641-650.

[32] Woods AJ, Antal A, Bikson M, et al. A technical guide to tDCS, and related non-invasive brain stimulation tools. Clin Neurophysiol. 2016; 127(2): 1031-1048.

[33] Flöel A. TDCS-enhanced motor and cognitive function in neurological diseases. Neuroimage. 2014; 85: 934-947.

[34] Lefaucheur JP, Antal A, Ayache SS, et al. Evidence-based guidelines on the therapeutic use of transcranial direct current stimulation (tDCS). Clin Neurophysiol. 2017; 128(1): 56-92.

[35] Yanagisawa H, Dan I, Tsuzuki D, et al. Acute moderate exercise elicits increased dorsolateral prefrontal activation and improves cognitive performance with Stroop test. Neuroimage. 2010; 50(4): 1702-1710.

[36] Holtzer R, Izzetoglu M. Mild cognitive impairments attenuate prefrontal cortex activations during walking in older adults. Brain Sci. 2020; 10(7):415.

[37] Anderson ND. State of the science on mild cognitive impairment (MCI). CNS Spectr. 2019; 24(1): 78-87.

[38] Kuhn J, Hardenacke K, Lenartz D, et al. Deep brain stimulation of the nucleus basalis of Meynert in Alzheimer's dementia. Mol Psychiatry. 2015; 20(3): 353-360.

[39] He H, Chen Y, Li X, et al. Decline in the integration of top-down and bottom-up attentional control in older adults with mild cognitive impairment. Neuropsychologia. 2021; 161:108014.

[40] Echeverri-Ocampo I, Ardila K, Molina-Mateo J, et al. EEG-based functional connectivity analysis for cognitive impairment classification. Electron. 2023; 12(21): 1-17.

[41] Parajuli M, Amara AW, Shaban M. Deep-learning detection of mild cognitive impairment from sleep electroencephalography for patients with Parkinson's disease. PLoS One. 2023; 18:0286506.

[42] Norris M, Oppenheim C. Comparing alternatives to the Web of Science for coverage of the social sciences' literature. J Informetrics. 2007; 1(2): 161-169.

[43] Chen C. The CiteSpace Manual. 2014;Vol 1.

[44] Ellegaard O, Wallin JA. The bibliometric analysis of scholarly production: how great is the impact? Scientometrics. 2015; 105(3): 1809-1831.

[45] Dzikowski P. A bibliometric analysis of born global firms. J Bus Res. 2018; 85: 281-294.

[46] Chen C. CiteSpace II: detecting and visualizing emerging trends and transient patterns In scientific literature. J Am Soc Inform Sci Technol. 2006; 57(3): 359-377.

[47] Chen C. Science mapping: a systematic review of the literature. J Data Inf Sci. 2017; 2(2): 1-40.

[48] Chen C, Chen Y, Horowitz M, Hou H, Liu Z, Pellegrino D. Towards an explanatory and computational theory of scientific discovery. J Informetrics. 2009; 3(3): 191-209.

[49] Chen C, Ibekwe-SanJuan F, Hou J. The structure and dynamics of cocitation clusters: a multiple-perspective cocitation analysis. J Am Soc Inf Sci Technol. 2010; 61(7): 1386-1409.

[50] Karim MA, Venkatachalam J. Global trends on studies with cognitive training: mapping and bibliometric analysis using CiteSpace. Cogn Brain, Behav An Interdiscip J. 2021; 25(4): 311-340.

[51] Kleinberg J. Bursty and hierarchical structure in streams. Data Min Knowl Discov. 2003; 7: 373-397.

[52] Zheng K, Wang X. Publications on the association between cognitive function and pain from 2000 to 2018: a bibliometric analysis using Citespace. Med Sci Monit. 2019; 25: 8940-8951.

[53] Spector A, Thorgrimsen L, Woods B, et al. Efficacy of an evidence-based cognitive stimulation therapy programme for people with dementia: randomised controlled trial. Br J Psychiatry. 2003; 183: 248-254.

[54] Stott J, Spector A. A review of the effectiveness of memory interventions in mild cognitive impairment (MCI). Int Psychogeriatr. 2011; 23(4): 526-538.

[55] Orrell M, Yates L, Leung P, et al. The impact of individual Cognitive Stimulation Therapy (iCST) on cognition, quality of life, caregiver health, and family relationships in dementia: a randomised controlled trial. PLoS Med. 2017; 14(3):e1002269.

[56] Orrell M, Yates LA, Burns A, et al. Individual Cognitive Stimulation Therapy for dementia (iCST): study protocol for a randomized controlled trial. Trials. 2012; 13:172.

[57] Orrell M, Aguirre E, Spector A, et al. Maintenance cognitive stimulation therapy for dementia: single-blind, multicentre, pragmatic randomised controlled trial. Br J Psychiatry. 2014; 204(6): 454-461.

[58] Lam J, Lee J, Liu CY, Lozano AM, Lee DJ. Deep brain stimulation for Alzheimer's disease: tackling circuit dysfunction. Neuromodulation: Technol Neural Interface. 2021; 24(2): 171-186.

[59] Lozano AM, Fosdick L, Chakravarty MM, et al. A phase II study of fornix deep brain stimulation in mild Alzheimer's disease. J Alzheimer's Dis. 2016; 54(2): 777-787.

[60] Tierney TS, Sankar T, Lozano AM. Deep brain stimulation. Emerging Indications. 194, 1st ed. Elsevier B.V; 2011.

[61] Mirzadeh Z, Bari A, Lozano AM. The rationale for deep brain stimulation in Alzheimer's disease. J Neural Transm. 2016; 123(7): 775-783.

[62] Buss SS, Fried PJ, Pascual-Leone A. Therapeutic noninvasive brain stimulation in Alzheimer's disease and related dementias. Curr Opin Neurol. 2019; 32(2): 292-304.

[63] Bréchet L, Michel CM, Schacter DL, Pascual-Leone A. Improving autobiographical memory in Alzheimer's disease by transcranial alternating current stimulation. Curr Opin Behav Sci. 2021; 40: 64-71.

[64] Koch G, Di Lorenzo F, Bonnì S, Ponzo V, Caltagirone C, Martorana A. Impaired LTP-but not LTD-like cortical plasticity in Alzheimer's disease patients. J Alzheimer's Dis. 2012; 31(3): 593-599.

[65] Koch G, Casula EP, Bonnì S, et al. Precuneus magnetic stimulation for Alzheimer's disease: a randomized, sham-controlled trial. Brain. 2022; 145(11): 3776-3786.

[66] Koch G, Bonnì S, Pellicciari MC, et al. Transcranial magnetic stimulation of the precuneus enhances memory and neural activity in prodromal Alzheimer's disease. Neuroimage. 2018; 169(2018): 302-311.

[67] Rasmusson DX, Brandt J, Steele C, Hedreen JC, Troncoso JC, Folstein MF. Accuracy of clinical diagnosis of Alzheimer disease and clinical features of patients with non-Alzheimer disease neuropathology. Alzheimer Dis Assoc Disorders. 1996; 10(4): 180-188.

[68] Petersen RC, Smith GE, Waring SC, Ivnik RJ, Tangalos EG, Kokmen E. Mild cognitive impairment: clinical characterization and outcome. Arch Neurol. 1999; 56(3): 303-308.

[69] Nitsche MA, Müller-Dahlhaus F, Paulus W, Ziemann U. The pharmacology of neuroplasticity induced by non-invasive brain stimulation: building models for the clinical use of CNS active drugs. J Physiol. 2012; 590(19): 4641-4662.

[70] Cotelli M, Calabria M, Manenti R, et al. Improved language performance in Alzheimer disease following brain stimulation. J Neurol Neurosurg Psychiatry. 2011; 82(7): 794-797.

[71] Aaslid R, Lindegaard KF, Sorteberg W, Nornes H. Cerebral autoregulation dynamics in humans. Stroke. 1989; 20(1): 45-52.

[72] Campion D, Dumanchin C, Hannequin D, et al. Early-onset autosomal dominant Alzheimer disease: prevalence, genetic heterogeneity, and mutation spectrum. Am J Human Genet. 1999; 65(3): 664-670.

[73] Rossini PM, Barker AT, Berardelli A, et al. Non-invasive electrical and magnetic stimulation of the brain, spinal cord and roots: basic principles and procedures for routine clinical application. Report of an IFCN committee. Electroencephalogr Clin Neurophysiol. 1994; 91(2): 79-92.

[74] McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group⋆ under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology. 1984; 34(7):939.

[75] Benabid AL, Krack PP, Benazzouz A, Limousin P, Koudsie A, Pollak P. Deep brain stimulation of the subthalamic nucleus for Parkinson's disease: methodologic aspects and clinical criteria. Neurology. 2000; 55(12 suppl 6): 40-44.

[76] Fahn S, Przedborski S. Parkinsonism. In: Lippincott , Williams , Wilkins NY, eds. Parkinsonism in Merritt's Neurology. Lippincott Williams & Wilkins; 2000: 679-693.

[77] Bella R, Ferri R, Pennisi M, et al. Enhanced motor cortex facilitation in patients with vascular cognitive impairment-no dementia. Neurosci Lett. 2011; 503(3): 171-175.

[78] Di Lazzaro V, Bella R, Benussi A, et al. Diagnostic contribution and therapeutic perspectives of transcranial magnetic stimulation in dementia. Clin Neurophysiol. 2021; 132(10): 2568-2607.

[79] Lefaucheur JP, Aleman A, Baeken C, et al. Evidence-based guidelines on the therapeutic use of repetitive transcranial magnetic stimulation (rTMS): an update (2014–2018). Clin Neurophysiol. 2020; 131(2): 474-528.

[80] Freitas C, Mondragón-Llorca H, Pascual-Leone A. Noninvasive brain stimulation in Alzheimer's disease: systematic review and perspectives for the future. Exp Gerontol. 2011; 46(8): 611-627.

[81] Hsu WY, Ku Y, Zanto TP, Gazzaley A. Effects of noninvasive brain stimulation on cognitive function in healthy aging and Alzheimer's disease: a systematic review and meta-analysis. Neurobiol Aging. 2015; 36(8): 2348-2359.

[82] Rossini PM, Rossi S, Babiloni C, Polich J. Clinical neurophysiology of aging brain: from normal aging to neurodegeneration. Prog Neurobiol. 2007; 83(6): 375-400.

[83] Nardone R, Höller Y, Tezzon F, et al. Neurostimulation in Alzheimer's disease: from basic research to clinical applications. Neurol Sci. 2015; 36(5): 689-700.

[84] Lefaucheur JP, André-Obadia N, Antal A, et al. Evidence-based guidelines on the therapeutic use of repetitive transcranial magnetic stimulation (rTMS). Clin Neurophysiol. 2014; 125(11): 2150-2206.

[85] Chang CH, Lane HY, Lin CH. Brain stimulation in Alzheimer's disease. Front Psychiatry. 2018; 9:201.

[86] Cotelli M, Manenti R, Brambilla M, et al. Anodal tDCS during face-name associations memory training in Alzheimer's patients. Front Aging Neurosci. 2014; 6:38.

[87] Prehn K, Flöel A. Potentials and limits to enhance cognitive functions in healthy and pathological aging by tDCS. Front Cell Neurosci. 2015; 9:355.

[88] Bartrés-Faz D, Vidal-Piñeiro D. Noninvasive brain stimulation for the study of memory enhancement in aging. Eur Psychologist. 2016; 21(1): 41-54.

[89] Liu CS, Herrmann N, Song BX, et al. Exercise priming with transcranial direct current stimulation: a study protocol for a randomized, parallel-design, sham-controlled trial in mild cognitive impairment and Alzheimer's disease. BMC Geriatr. 2021; 21(1): 677.

[90] Olanow CW, Stern MB, Sethi K. The scientific and clinical basis for the treatment of Parkinson disease (2009). Neurology. 2009; 72(21 suppl 4): 1-136.

[91] Sethi K. Levodopa unresponsive symptoms in Parkinson disease. Mov Disorders. 2008; 23(suppl 3): S521-S533.

[92] Weintraub D, Burn DJ. Parkinson's disease: the quintessential neuropsychiatric disorder. Mov Disorders. 2011; 26(6): 1022-1031.

[93] Pople CB, Meng Y, Li DZ, et al. Neuromodulation in the treatment of Alzheimer's disease: current and emerging approaches. J Alzheimer's Dis. 2020; 78(4): 1299-1313.

[94] Posporelis S, David AS, Ashkan K, Shotbolt P. Deep brain stimulation of the memory circuit: improving cognition in Alzheimer's disease. J Alzheimer's Dis. 2018; 64(2): 337-347.

[95] Hescham S, Lim LW, Jahanshahi A, Blokland A, Temel Y. Deep brain stimulation in dementia-related disorders. Neurosci Biobehav Rev. 2013; 37(10): 2666-2675.

[96] Mimenza-Alvarado AJ, Aguilar-Navarro SG, Martinez-Carrillo FM, Ríos-Ponce AE, Villafuerte G. Use of fast gamma magnetic stimulation over the left prefrontal dorsolateral cortex for the treatment of MCI and mild Alzheimer's disease: a double-blind, randomized, sham-controlled, pilot study. Front Neurol. 2021; 12:729872.

[97] Roda AR, Esquerda-Canals G, Martí-Clúa J, Villegas S. Cognitive impairment in the 3xtg-ad mouse model of Alzheimer's disease is affected by aβ-immunotherapy and cognitive stimulation. Pharmaceutics. 2020; 12(10):944.

[98] Rajji TK. Impaired brain plasticity as a potential therapeutic target for treatment and prevention of dementia. Expert Opin Ther Targets. 2019; 23(1): 21-28.

RIGHTS & PERMISSIONS

2025 The Author(s). Ibrain published by Affiliated Hospital of Zunyi Medical University and Wiley-VCH GmbH.